Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection

SIMPLE SUMMARY: The current metastatic colorectal cancer guidelines suggest intensive systemic chemotherapy with a targeted agent, rather than surgical resection, as first-line treatment for primary colorectal tumor and distant metastasis. However, results of comparative efficacy between bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yi-Chia, Wu, Chih-Chien, Su, Chien-Chou, Hsieh, Meng-Che, Cheng, Ching-Lan, Kao Yang, Yea-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104998/
https://www.ncbi.nlm.nih.gov/pubmed/35565247
http://dx.doi.org/10.3390/cancers14092118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104998/
https://www.ncbi.nlm.nih.gov/pubmed/35565247
http://dx.doi.org/10.3390/cancers14092118

Ejemplares similares